Cargando…
Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury
It has been established that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses angiotensin-converting enzyme 2 (ACE2), a membrane-bound regulatory peptide, for host cell entry. Renin-angiotensin-aldosterone system (RAAS) inhibitors have been reported to increase ACE2 in type 2 pneumo...
Autores principales: | Ventura, Davide, Carr, Amy L, Davis, R Duane, Silvestry, Scott, Bogar, Linda, Raval, Nirav, Gries, Cynthia, Hayes, Jillian E, Oliveira, Eduardo, Sniffen, Jason, Allison, Steven L, Herrera, Victor, Jennings, Douglas L, Page, Robert L, McDyer, John F, Ensor, Christopher R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083494/ https://www.ncbi.nlm.nih.gov/pubmed/34642634 http://dx.doi.org/10.1093/ofid/ofab170 |
Ejemplares similares
-
Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020) -
The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies
por: Ortiz, Rudy M., et al.
Publicado: (2023) -
Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012) -
Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014) -
The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)